PubMed:16609016 / 265-669 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/16609016","sourcedb":"PubMed","sourceid":"16609016","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/16609016","text":"RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19","tracks":[{"project":"DisGeNET5_gene_disease","denotations":[{"id":"16609016-0#0#21#gene6143","span":{"begin":0,"end":404},"obj":"gene6143"}],"attributes":[{"subj":"16609016-0#0#21#gene6143","pred":"source","obj":"DisGeNET5_gene_disease"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"DisGeNET5_gene_disease","color":"#96ec93","default":true}]}]}}